Paper34582425
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL and 5 others. Crit Care Med, 2022. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. Papers, record 34582425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34582425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Shock, Septic | Major topic |
| Adult | |
| Catecholamines | |
| Humans | |
| Lactic Acid | |
| Norepinephrine | |
| Retrospective Studies | |
| Vasoconstrictor Agents | |
| Vasopressins |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06709573 | Early Versus Late Adjunctive Vasopressin in Septic Shock | Results |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 35311781 | Early Multimodal Vasopressors-Are We Ready for It? | https://conductscience.org/library/papers/35311781 | PubMed |
| Comment in | 36106977 | Potential Confounders in Study Concluding Higher Lactate at Vasopressin Initiation Is Associated With Higher Mortality in Septic Shock. | https://conductscience.org/library/papers/36106977 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42907944 | Pharmacology of vasopressors and inotropes during extracorporeal membrane oxygenation. | J Anesth Analg Crit Care | 2026 | https://conductscience.org/library/papers/42907944 | PubMed |
| 42891135 | Vasopressin for hypotensive paediatric intensive care patients: an ESPNIC endorsed international survey: the P-PRESS survey. | Ann Intensive Care | 2026 | https://conductscience.org/library/papers/42891135 | PubMed |
| 42846417 | Early adjunctive vasopressin was not associated with a lower 7-day risk of renal replacement therapy in norepinephrine-treated patients with cirrhosis: a target-trial-informed study with external replication. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42846417 | PubMed |
| 42839245 | Clinical trials testing early multimodal vasopressor therapy require a dose ceiling, not a dose floor. | Crit Care | 2026 | https://conductscience.org/library/papers/42839245 | PubMed |
| 42831066 | High blood pressure-targeted management associated with reduced benefits of higher body mass index in elderly patients with septic shock: a post hoc analysis of a multicenter randomized controlled trial. | Ann Intensive Care | 2026 | https://conductscience.org/library/papers/42831066 | PubMed |
| 42766803 | Development and Validation of an Interpretable Machine Learning Model to Predict Mortality in Patients With Sepsis-Induced Coagulopathy: Multicenter Cohort Study. | JMIR Med Inform | 2026 | https://conductscience.org/library/papers/42766803 | PubMed |
| 42739840 | Association Between Lactate Trajectories and Clinical Outcomes in Critically Ill Patients with Sepsis-Associated Liver Injury. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739840 | PubMed |
| 42565049 | Severity-stratified vasopressor-escalation strategies in septic shock: a cross-fitted doubly robust analysis with external replication. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42565049 | PubMed |
| 42329498 | Noradrenaline-trajectory phenotypes in septic shock: derivation and external validation in two independent cohorts. | Intensive Care Med Exp | 2026 | https://conductscience.org/library/papers/42329498 | PubMed |
| 42277950 | Current and future strategies aiming at reducing catecholamine exposure in septic shock. | Crit Care | 2026 | https://conductscience.org/library/papers/42277950 | PubMed |
| 42090639 | Effect of Weight-based versus Absolute Norepinephrine Dosing on Mortality Risk in Obese Patients with Septic Shock: An Observational, Multicohort, Retrospective Study. | Anesthesiology | 2026 | https://conductscience.org/library/papers/42090639 | PubMed |
| 41870792 | Efficacy and Safety of Shenfu Injection in Patients with Septic Shock: A Randomized Controlled Open-Label Trial with Network Pharmacology-Based Mechanistic Insights. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/41870792 | PubMed |
| 41736777 | When should we start vasopressin in septic shock? Revisiting an old question. | J Intensive Med | 2026 | https://conductscience.org/library/papers/41736777 | PubMed |
| 41580807 | Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trial. | Scand J Trauma Resusc Emerg Med | 2026 | https://conductscience.org/library/papers/41580807 | PubMed |
| 41210542 | Early Vasopressin in Septic Shock-Promise, Paradox, and the Pursuit of Precision. | Indian J Crit Care Med | 2025 | https://conductscience.org/library/papers/41210542 | PubMed |
| 41210535 | Timing of Vasopressin Initiation in Patients with Septic Shock: An Updated Systematic Review and Meta-analysis with Trial Sequential Analysis. | Indian J Crit Care Med | 2025 | https://conductscience.org/library/papers/41210535 | PubMed |
| 41024303 | Clinical characteristics associated with septic shock complicating hypothermia: a retrospective cohort study from the MIMIC-IV database. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41024303 | PubMed |
| 40989844 | Post-translational modifications in sepsis-induced acute kidney injury: mechanisms and perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40989844 | PubMed |
| 40924922 | It's Time to Consider How We Should Use Vasopressors, Rather Than Just Which We Should Use. | Crit Care Explor | 2025 | https://conductscience.org/library/papers/40924922 | PubMed |
| 40844800 | Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases. | Crit Care Explor | 2025 | https://conductscience.org/library/papers/40844800 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| VASOPRESSIN | CHEMBL373742 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL373742 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34582425
GET https://conductscience.org/api/papers/v1/34582425/cited_by?page=2